<html>
<head>PUBMED IDs for mGlu2</head>
<body bgcolor='#C5F0F2'><h1>mGlu2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10219974/'>Design and models for estimating antagonist potency (pA2, Kd and IC50) following the detection of antagonism observed in the presence of intrinsic activity.</a> April 29  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10797311/'>Expression of functional mGlu5 metabotropic glutamate receptors in human melanocytes.</a> May 8  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/14694349/'>Anxiolytic activity of the MGLU2/3 receptor agonist LY354740 on the elevated plus maze is associated with the suppression of stress-induced c-Fos in the hippocampus and increases in c-Fos induction in several other stress-sensitive brain regions.</a> December 25  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14694305/'>Transmigration across a lung epithelial monolayer delays apoptosis of polymorphonuclear leukocytes.</a> December 25  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16764720/'>Transcriptional regulation of metabotropic glutamate receptor 2/3 expression by the NF-kappaB pathway in primary dorsal root ganglia neurons: a possible mechanism for the analgesic effect of L-acetylcarnitine.</a> June 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16764716/'>Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy.</a> June 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16764710/'>Evaluation of the persistence and gene expression of an anti-Chlamydophila psittaci DNA vaccine in turkey muscle.</a> June 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16764708/'>Dilated cardiomyopathy: a tale of cytoskeletal proteins and beyond.</a> June 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17982252/'>Molecular mechanisms of schizophrenia.</a> November 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18520992/'>Morphine withdrawal increases metabotropic glutamate 2/3 receptors expression in nucleus accumbens.</a> June 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18520958/'>Latent class subtyping of attention-deficit/hyperactivity disorder and comorbid conditions.</a> June 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19945495/'>Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression.</a> May 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20082658/'>Early defect of transforming growth factor Î²1 formation in Huntington's disease.</a> July 23  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21173788/'>Pharmacogenetic analysis of the mGlu2/3 agonist LY2140023 monohydrate in the treatment of schizophrenia.</a> September 18  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22864611/'>HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.</a> November 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23382250/'>L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors.</a> May 25  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25150943/'>Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.</a> July 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26044978/'>When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic Efficacy.</a> June 4  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26658273/'>mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in Rats.</a> June 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26813121/'>Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review.</a> December 30  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27218869/'>Group II mGluRs suppress hyperexcitability in mouse and human nociceptors.</a> March 7  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27354525/'>Epigenetics and energetics in ventral hippocampus mediate rapid antidepressant action: Implications for treatment resistance.</a> June 30  2016<br></body></html>
